Activity Overview
This educational activity is an archive of the live conference held from February 26, 2026, through February 28, 2026.
Target Audience
This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
Learning Objectives
Upon participation in this activity, learners will be better able to:
- Evaluate recent clinical trial results on approved and emerging therapeutic approaches for patients with hematologic disorders
Ajai Chari, MD
Professor, Medicine
Director, Multiple Myeloma Program
UCSF Helen Diller Family Comprehensive Cancer
Center
University of California, San Francisco
(UCSF) Medical Center
San Francisco, CA
María-Victoria Mateos, MD, PhD
Associate Professor of Medicine
Director, Myeloma Program
University of Salamanca
Salamanca, Spain
Luciano J. Costa, MD, PhD
Mary and Bill Battle Professor of Multiple
Myeloma
Director, Multiple Myeloma Research and
Treatment Program
O’Neal Comprehensive Cancer Center
The University of Alabama at Birmingham
Birmingham, AL
C. Ola Landgren, MD, PhD
Professor of Medicine
Chief, Division of Myeloma, Department of
Medicine
Director, Sylvester Myeloma Institute
Co-Leader, Translational and Clinical
Oncology Program
Paul J. DiMare Endowed Chair in Immunotherapy
Sylvester Comprehensive Cancer Center
University of Miami
Don Soffer Clinical Research Center
Miami, FL
Suzanne Lentzsch, MD, PhD
Professor of Medicine at Columbia University
Director, Multiple Myeloma and Amyloidosis
Service
Columbia University Irving Medical Center
New York, NY
Mohamad Mohty, MD, PhD
Professor of Hematology
Sorbonne University
Head, Clinical Hematology and Cellular
Therapy Department
Saint-Antoine Hospital
Paris, France
Krina Patel, MD, MSc
Associate Professor
Multiple Myeloma Section Chief
Director, Myeloma Clinical Research
Department of Lymphoma/Myeloma
The University of Texas MD Anderson Cancer
Center
Houston, TX
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
